clinical trial · NCT06434103
Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.·phase2·withdrawn
Advanced Non-small Cell Lung CancerSHR-A1921；Adebrelimab；SHR-8068；carboplatin
brief summary
A trial to evaluate the tolerability and efficacy of SHR-A1921 in combination with adbelizumab and SHR-8068 with or without carboplatin in patients with advanced non-small cell lung cancer
started
Oct 10, 2024
primary completion
Oct 10, 2024
completion
Oct 10, 2024
last updated
Apr 8, 2026
official title
An Open, Multicenter Phase I/II Trial of SHR-A1921 in Combination With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol